Literature DB >> 1284654

Antigen-antibody interactions: elucidation of the epitope and strain-specificity of a monoclonal antibody directed against the pilin protein adherence binding domain of Pseudomonas aeruginosa strain K.

W Y Wong1, R T Irvin, W Paranchych, R S Hodges.   

Abstract

The C-terminal region of Pseudomonas aeruginosa strain K (PAK) pilin comprises both an epitope for the strain-specific monoclonal antibody PK99H, which blocks pilus-mediated adherence, and the adherence binding domain for buccal and tracheal epithelial cells. The PK99H epitope was located in sequence 134-140 (Asp-Glu-Gln-Phe-Ile-Pro-Lys) by using a single alanine replacement analysis on the 17-residue synthetic peptide corresponding to the PAK C-terminal sequence 128-144. Indeed, a 7-residue peptide corresponding to this sequence was shown to have a similar binding affinity to that of the native conformationally constrained (disulfide bridged) 17-residue peptide. This epitope was found to contain two critical residues (Phe137 and Lys140) and one nonessential residue (Gln136). Interestingly, the peptide, Phe-Ile-Pro-Lys, which constitutes the four most important side chains for antibody binding did not bind to PK99H. It was of interest to investigate the structural basis of the strain-specificity of PK99H utilizing naturally occurring pilin sequences. Therefore, all different residues found in the sequence corresponding to the PK99H epitope of the four other strains (PAO, CD4, K122-4, and KB7) were substituted one at a time in the PAK sequence and the changes in binding affinity of these analogs to the antibody PK99H were determined by competitive ELISA. The strain-specificity of PK99H for strains PAO, K122-4, and KB7 can be explained by the accumulated sequence changes in these strains, and at least two amino acid changes were required to explain the strain-specificity of PK99H. Similarly, cross-reactivity of PK99H with CD4 can be explained by the fact that there was only one side chain responsible for decreasing binding affinity compared to the PAK sequence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284654      PMCID: PMC2142108          DOI: 10.1002/pro.5560011010

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  36 in total

1.  Effect of variations in peptide sequence on anti-human milk fat globule membrane antibody reactions.

Authors:  P X Xing; K Reynolds; G A Pietersz; I F McKenzie
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

Review 2.  Intrinsic and extrinsic factors in protein antigenic structure.

Authors:  J A Berzofsky
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

3.  New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites.

Authors:  J M Parker; D Guo; R S Hodges
Journal:  Biochemistry       Date:  1986-09-23       Impact factor: 3.162

4.  Characterization of the binding of Pseudomonas aeruginosa alginate to human epithelial cells.

Authors:  P Doig; N R Smith; T Todd; R T Irvin
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

5.  Synthetic model for two-stranded alpha-helical coiled-coils. Design, synthesis, and characterization of an 86-residue analog of tropomyosin.

Authors:  R S Hodges; A K Saund; P C Chong; S A St-Pierre; R E Reid
Journal:  J Biol Chem       Date:  1981-02-10       Impact factor: 5.157

6.  Alteration of pulmonary structure by Pseudomonas aeruginosa exoenzyme S.

Authors:  D E Woods; W S Hwang; M S Shahrabadi; J U Que
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

7.  Comparative studies of the amino acid and nucleotide sequences of pilin derived from Pseudomonas aeruginosa PAK and PAO.

Authors:  P A Sastry; B B Finlay; B L Pasloske; W Paranchych; J R Pearlstone; L B Smillie
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490

8.  Fimbriae (pili): molecular basis of Pseudomonas aeruginosa adherence.

Authors:  W Paranchych; P A Sastry; K Volpel; B A Loh; D P Speert
Journal:  Clin Invest Med       Date:  1986       Impact factor: 0.825

9.  Inhibition of pilus-mediated adhesion of Pseudomonas aeruginosa to human buccal epithelial cells by monoclonal antibodies directed against pili.

Authors:  P Doig; P A Sastry; R S Hodges; K K Lee; W Paranchych; R T Irvin
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

Review 10.  Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis.

Authors:  T L Pitt
Journal:  J R Soc Med       Date:  1986       Impact factor: 18.000

View more
  6 in total

1.  Characterizing the microenvironment surrounding protein sites.

Authors:  S C Bagley; R B Altman
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

2.  Anti-peptide monoclonal antibody imaging of a common binding domain involved in muscle regulation.

Authors:  J E Van Eyk; R A Caday-Malcolm; L Yu; R T Irvin; R S Hodges
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

3.  Synthetic peptide vaccine development: designing dual epitopes into a single pilin peptide immunogen generates antibody cross-reactivity between two strains of Pseudomonas aeruginosa.

Authors:  Clifton Hackbarth; Robert S Hodges
Journal:  Chem Biol Drug Des       Date:  2010-08-30       Impact factor: 2.817

4.  Animal protection and structural studies of a consensus sequence vaccine targeting the receptor binding domain of the type IV pilus of Pseudomonas aeruginosa.

Authors:  Daniel J Kao; Mair E A Churchill; Randall T Irvin; Robert S Hodges
Journal:  J Mol Biol       Date:  2007-09-19       Impact factor: 5.469

5.  Adherence of Pseudomonas aeruginosa and Candida albicans to glycosphingolipid (Asialo-GM1) receptors is achieved by a conserved receptor-binding domain present on their adhesins.

Authors:  L Yu; K K Lee; R S Hodges; W Paranchych; R T Irvin
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Incorporating TiO2 nanotubes with a peptide of D-amino K122-4 (D) for enhanced mechanical and photocatalytic properties.

Authors:  L Q Guo; Y W Hu; B Yu; E Davis; R Irvin; X G Yan; D Y Li
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.